Update on the vaccination of the child traveler and…

tick-borne encephalitis Ticovac® child 1 year to 15 years 3 doses: D0, M1-M3, M5-M12 after D2
3-dose accelerated regimen: 0, D14, M5-M12 after D2 3 years after D3, then every 5 years Ticovac® adulte ≥ 16 ans Encepur® ≥ 12 ans 3 doses: D0, M1-M3, M9-M12 after D2
3-dose accelerated regimen: J0, J7, J21 3 years after D3 after conventional regimen or 12 to 18 months after D3 if accelerated scheme, then every 5 years between 12 and 49 years Interchangeability: oui, except accelerated scheme Japanese encephalitis Ixiaro® ≥ 2 months* 2 doses : J0, J28 12-24 months after D2, (12 months if continuously exposed to risk) *1/2 dose from 2 months to 3 years
Interchangeability: exclusively with the vaccin JEEV (Biological E Ltd) produced in India
No long-term protection data Yellow fever Stamaril® ≥ 9 months
(≥ 6 months*) 1 dose 2^e recommended dose: (1) in the event of new exposure to the risk from the age of 6 if 1^ere dose before the age of 2 years, (2) if the initial vaccination dates back more than 10 years (2.a) in the event of a stay in a country where the active circulation of the virus is reported or (2.b) in HIV-infected or immunocompromised people with no contraindication to vaccination (Table 2) * ≥ 6 months if epidemic in progress or rural or forest stay
Deadline for the MMR vaccine.
Notify in a CVI Hepatitis A Havrix 720® 1 an – 15 ans 1 dose M6 to M12, up to 5 years after D1 Avaxim 80® M6 to M36, up to 7 years after D1 Havrix 1440® ≥ 16 ans M6 to M12, up to 5 years after D1 Avaxim 160® M6 to M12, up to 36 months after D1 Twinrix® adulte 3 doses : J0, M1, M6 No reminder Tyavax® (see Typhoid) Interchangeability : yes for monovalent hepatitis A vaccines
In subjects ≥ 16 years old not vaccinated against hepatitis B, choose the Twinrix® vaccine.
If protection against typhoid fever is also desirable during the booster, the Tyavax® vaccine can be used preferably between M6-M12 and up to 36 months after the 1^time hepatitis A dose Meningitis A, C, W, Y Nimenrix® ≥ 6 weeks at 6M 2 doses spaced 2 months apart Primary vaccination completed between 6 weeks to 12 months: booster from the age of 12 months, at least 2 months after the last dose
Age ≥ 12M and primary vaccination completed: booster every 5 years if exposure to risk persists ≥ 6 months 1 dose Menquadfi® ≥ 12 months 1 dose Data regarding the need for a booster dose, or the associated delay, are not available. Menveo® ≥ 2 ans 1 dose Every 5 years if exposure to risk persists Interchangeability : if recall after the age of 2 years
Respect a delay of 1 month between vaccines against meningitis A, C, W, Y and vaccines Neisvac® or Menjugate®
For pilgrimage: notify in a CVI (Duration of administrative validity: 5 years) Rage Rabies vaccine Pasteur® walking age 3 doses: D0, D7, D21 or D28
Shortened 2-dose regimen (WHO):D0, D7 (Per session: 0.1 ml ID in 2 sites or, 1 dose IM) None Rabipur® Interchangeability: oui
The shortened OMS regimen is off-label.If indication of post-exposure prophylaxis AND complete primary vaccination documented (travel with proof of vaccination): local treatment of the wound AND booster vaccination (1 IM dose on D0 and D3 or 4 ID doses of 0.1 mL at 4 sites on D0 exclusively with the Rabies Vaccine Pasteur®) AND no use of immunoglobulins Typhoid Typhim VI® ≥  2 ans 1 dose New dose(s): Every 3 years if exposure to risk is maintained Tyavax® ≥  16 ans 1 dose Hepatitis A: M6 to M12, up to 36 months after 1^time dose with monovalent hepatitis A vaccine
Hepatitis A and typhoid: 36 months after 1^time dose with Tyavax® Efficacy for typhoid: 50-65% with protection for 3 years Poliomyelitis Age minimum : ≥ 2 months
In all cases, it seems consistent to contraindicate the stay in the absence of a complete primary vaccination schedule completed at least 4 weeks before departure.
– Stay of less than 4 weeks in one of the countries infected by the polio virus:The traveling child must meet the recommendations of the French vaccination schedule. Incomplete poliomyelitis vaccinations must be completed at least 3 weeks before departure.
Depending on previous vaccinations and the age of the child, a combined hexa- (DTCPHib HepB), penta- (DTCPHib) or tetravalent (DTCP or dTcP) vaccine will be administered.

– Stay of more than 4 weeks or expatriation in one of the countries infected by polio viruses

. stay of less than 12 months: a reminder will be given before departure, ideally 4 weeks before departure;

. stay of more than one year: a booster will be administered in the country of stay, more than 4 weeks (immunization period) and less than 12 months before return.

A non-combined trivalent inactivated polio vaccine (Imovax Polio®) can be used in children up to date with their vaccination against diphtheria, tetanus and whooping cough.
In children who are not up to date (catch-up vaccination or current vaccination schedule): combined hexa- (DTCPHib HepB), penta- (DTCPHib) or tetravalent (DTCP or dTcP) vaccine depending on previous vaccination and age.
It is recommended that these polio vaccine boosters be mentioned on the WHO International Vaccination Certificate.